Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

830 projects found matching your search criteria :

  1. Targeting MMP-9 in Cancer Treatment: Computational Design and Experimental Validation of Potent, Safe Antitumor Agents

    Call: SONATA BIS 15 , Panel: ST5

    Principal investigator: dr Anna Żądło-Dobrowolska

    Instytut Chemii Organicznej Polska Akademia Nauk

  2. Development of Molecular and Supramolecular Tools to Exploit Human Copper(I) Homeostasis for Cancer Therapeutics

    Call: SONATA BIS 15 , Panel: ST5

    Principal investigator: dr JEENA Manayath Thekkeyil

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  3. Integrative analysis of tRNA modification circuits and aminoacylation and their role in breast cancer model.

    Call: OPUS 29 , Panel: NZ2

    Principal investigator: dr Marcin Sajek

    Instytut Genetyki Człowieka PAN

  4. ECLECTIC: Endometrial Cancer multiLayered Evaluation of Clinico-Metabo-Histo-Molecular data for Translational Integrativ...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Julia Zelkowska

    Uniwersytet Medyczny w Białymstoku

  5. Proteomic characterization, transcriptional and epigenetic regulation of drugtransporters in colorectal cancer

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Nina Ewa Komaniecka

    Pomorski Uniwersytet Medyczny w Szczecinie

  6. Role of the BRM- ERα interaction in the conferring of resistance to paclitaxel in BRG1-deficient cancers

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Karolina Gronkowska

    Uniwersytet Łódzki

  7. Effect of dietary modulation of RAGE/AGE axis on prostatic neuroendocrine differentiation and the efficacy of anticancer...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Wawrzyniec Dobrucki

    Gdański Uniwersytet Medyczny

  8. Molecular pathways involved in nuclear membrane stress adaptation and its role in breast and prostate cancer

    Call: OPUS 29 , Panel: NZ3

    Principal investigator: dr Paulina Nastały

    Gdański Uniwersytet Medyczny

  9. M. bovis BCG extracellular vesicles as an alternative in bladder cancer immunotherapy

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Jakub Smoliński

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  10. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Weronika Wojtyś

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  11. Development of Red-Emitting Chiral Carbon Dots for Advanced Photodynamic Therapy (PDT)

    Call: PRELUDIUM 24 , Panel: ST8

    Principal investigator: Patryk Szymaszek

    Politechnika Krakowska im. Tadeusza Kościuszki

  12. Development of the fluorescence multifunctional biosensing system based on antisense oligonucleotide probes for the onco...

    Call: PRELUDIUM 24 , Panel: ST4

    Principal investigator: Hubert Grzegorz Grel

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  13. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Robert Czarnomysy

    Uniwersytet Medyczny w Białymstoku

  14. Metabolic biomarkers of prostate cancer

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Tomasz Łukasz Ruman

    Politechnika Rzeszowska im. Ignacego Łukasiewicza

  15. Simulation of complex biological systems assisted by artificial intelligence: language-controlled model for cancer thera...

    Call: OPUS 29 , Panel: ST6

    Principal investigator: prof. Witold Dzwinel

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  16. LLT1 as a regulator of the immune response and a dual-target immunotherapy approach in colorectal cancer directed at NK ...

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr Marzena Dorota Lenart

    Uniwersytet Jagielloński

  17. "The Role of Adipose Tissue and microRNA in the Progression of Clear Cell RenalCell Carcinoma".

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Dorota Małgorzata Kwapisz

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  18. UVC Persistent Phosphors for Next-Generation Photodynamic Cancer Therapy

    Call: OPUS 29 , Panel: ST4

    Principal investigator: dr Nadiia Rebrova

    Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

  19. Rola TRIM32 i TRIM34 w regulacji metabolizmu guza i mikrośrodowiska immunologicznego w raku jajnika

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Alicja Katarzyna Rajtak

    Uniwersytet Medyczny w Lublinie

  20. The role of inflammation and sex-specific mechanisms in the development and progression of hepatocellular carcinoma

    Call: OPUS 29 , Panel: NZ4

    Principal investigator: dr hab. Katarzyna Miękus

    Uniwersytet Jagielloński

  21. We are Left Without Oxygen—Now What?: Evaluation of Hypoxia-Inducible COL Family Genes in Glioblastoma Patients and Thei...

    Call: OPUS 29 , Panel: NZ4

    Principal investigator: prof. Ewa Izabela Balcerczak

    Uniwersytet Medyczny w Łodzi

  22. Smart Multiscale Encapsulation System: Hydrogel Macrocapsules with LbL Nanoparticles for Colorectal Cancer Treatment

    Call: PRELUDIUM 24 , Panel: ST11

    Principal investigator: Joanna Irena Szechyńska

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  23. Intestinal barrier dysfunction as a risk factor for pancreatic ductal adenocarcinoma: impact of fatty acid intake, with ...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Wojciech Michał Jankowski

    Uniwersytet Medyczny w Łodzi

  24. New aryl difluoromethylenephosphonic acid and thiazole conjugates as effective PTP1B inhibitors used in the treatment of...

    Call: PRELUDIUM 24 , Panel: ST5

    Principal investigator: Dominika Agnieszka Kołodziej-Sobczak

    Uniwersytet Mikołaja Kopernika

  25. New violacein derivatives as candidates for sonodynamic therapy against skin cancer

    Call: SONATINA 9 , Panel: NZ7

    Principal investigator: dr Daniel Ryszard Ziental

    Uniwersytet Przyrodniczy w Poznaniu

  26. Artificial intelligence in predicting treatment outcomes of abdominal cancers – implementation of machine learning and d...

    Call: SONATINA 9 , Panel: NZ7

    Principal investigator: dr Krzysztof Bartnik

    Politechnika Warszawska

  27. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  28. Alterations in host protein trafficking during Human papillomavirus infection and oncogenesis

    Call: WEAVE-UNISONO , Panel: NZ6

    Principal investigator: dr hab. Justyna Karolina Broniarczyk

    Uniwersytet im. Adama Mickiewicza w Poznaniu

  29. Developing histone deacetylase-inhibiting hybrid analogs of pleurocidin and their potential in the treatment of HPV-indu...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr hab. Ewelina Piktel

    Uniwersytet Medyczny w Białymstoku

  30. Reciprocal relationships in metastatic colorectal cancer and its niche – from adaptation to host organs to induced paren...

    Call: OPUS 28 (LAP) , Panel: NZ2

    Principal investigator: dr Michał Artur Bieńkowski

    Gdański Uniwersytet Medyczny

  31. Mind the gap! Plasmonic nanocavity for spectroscopic trapping of local molecularrearrangements in DNA upon epigenetic mo...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: prof. Ewelina Wioletta Lipiec

    Uniwersytet Jagielloński

  32. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: dr hab. Bożena Anna Tyliszczak

    Politechnika Krakowska im. Tadeusza Kościuszki

  33. New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

  34. An innovative approach to the elimination of cancer cells in disseminated ovarian cancer in various preclinical models b...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr hab. Joanna Ewa Jazowiecka-Rakus

    Kardio-Med Silesia Sp. z o.o.

  35. Targeting Telomere Integrity as an Approach to Eradicate Cancer Cells

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Natalia Anna Maciejewska

    Politechnika Gdańska

  36. 3d genome re-organization during induced senescence in pancreatic cancer – insights from analysis of single chromatin fi...

    Call: OPUS 28 (LAP) , Panel: NZ5

    Principal investigator: dr hab. Michał Ryszard Gdula

    Uniwersytet im. Adama Mickiewicza w Poznaniu

  37. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  38. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  39. Changes in the oral microbiome as an early cancer marker

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr hab. Maja Kosecka-Strojek

    Uniwersytet Jagielloński

  40. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  41. Analysis of the effects of proteotoxic stress on cholesterol homeostasis and its associations with cardiovascular diseas...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Wiesława Elżbieta Widłak

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  42. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap...

    Call: OPUS 28 , Panel: NZ3

    Principal investigator: prof. Jarosław Piotr Czyż

    Uniwersytet Jagielloński

  43. Non-canonical Estrogen Receptor (ER) signalling in breast cancer progression

    Call: OPUS 28 , Panel: NZ3

    Principal investigator: prof. Rafał Sebastian Sądej

    Gdański Uniwersytet Medyczny

  44. Aptamer-mediated SERS/DEP Biosensors for proteomic analysis of extracellular vesicles of salivary gland tumors: towards ...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: prof. Agnieszka Edyta Michota-Kamińska

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  45. Harnessing NK cells and Graphene Oxide Nanoparticles for Pancreatic Ductal Adenocarcinoma Immunotherapy

    Call: OPUS 28 (LAP) , Panel: NZ7

    Principal investigator: prof. Iwona Maria Inkielewicz-Stępniak

    Gdański Uniwersytet Medyczny

  46. Canonical and non-canonical roles of DDK in oncogenesis: a cornerstone for the development of novel, potent anticancer t...

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Jan Marian Suski

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  47. Supramolecular nanoparticles able to block calcium channels in cancer cells

    Call: SONATA BIS 14 , Panel: ST11

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych PAN

  48. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  49. Molecular factors and pathomechanism of cancer-associated cachexia.

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Marcin Tomasz Skrzypski

    Gdański Uniwersytet Medyczny

  50. ERβ-mediated autophagy in colorectal cancer and its impact on carcinogenesis

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Julia Maria Lipowicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu